<DOC>
	<DOC>NCT00143416</DOC>
	<brief_summary>Primary objective: To investigate the efficacy and safety of Pegvisomant in Japanese patients with acromegaly.</brief_summary>
	<brief_title>Long Term Study With B2036-PEG</brief_title>
	<detailed_description />
	<mesh_term>Acromegaly</mesh_term>
	<criteria>Patients with acromegaly who have received at least one dose of B2036PEG in the preceding study (A6291009). Switching to other therapeutic methods for acromegaly</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2008</verification_date>
</DOC>